Daniel Henderson
Impact in
- Genetics top 1%
- Virus-based gene therapy research
Papers in
-
- Prostate Cancer Diagnosis and Treatment 10
- Genetics 13
- Virus-based gene therapy research 11
- Co-authors
- Orly Tamir (1 shared paper)Cyrus K. Yamin (1 shared paper)Calvin Franz (1 shared paper)Carol Ann Keohane (1 shared paper)Eyal Zimlichman (1 shared paper)David Westfall Bates (1 shared paper)Peter X.‐K. Song (1 shared paper)Charles R. Denham (1 shared paper)
- Journals
- Clinical Oncology (7 papers)The Lancet Oncology (2 papers)Vaccine (2 papers)European Urology (2 papers)Journal of Applied Physiology (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Daniel Henderson
54 papers receiving 5.0k citations
Daniel Henderson's Hit Papers
Peers
Comparison fields: 5 of 152
- Genetics 1.7k
- Critical Care and Intensive Care Medicine 203
- Pulmonary and Respiratory Medicine 1.2k
- Oncology 980
- Biotechnology 337
Countries citing papers authored by Daniel Henderson
This map shows the geographic impact of Daniel Henderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Henderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Henderson more than expected).
Fields of papers citing papers by Daniel Henderson
This network shows the impact of papers produced by Daniel Henderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Henderson. The network helps show where Daniel Henderson may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Henderson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Health Care–Associated Infections Hit paper breakdown → | 2013 | 1479 |
| 2 | Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells. | 1997 | 501 |
| 3 | Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial Hit paper breakdown → | 2019 | 412 |
| 4 | A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy. | 2001 | 329 |
| 5 | 1996 | 269 | |
| 6 | 2015 | 238 | |
| 7 | Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial Hit paper breakdown → | 2022 | 211 |
| 8 | The addition of adenovirus type 5 region E3 enables calydon virus 787 to eliminate distant prostate tumor xenografts. | 1999 | 198 |
| 9 | 2015 | 167 | |
| 10 | Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy. | 1999 | 162 |
| 11 | Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel. | 2001 | 156 |
| 12 | CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity. | 2001 | 139 |
| 13 | A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin. | 2001 | 131 |
| 14 | 2000 | 124 | |
| 15 | 1986 | 106 | |
| 16 | 2016 | 100 | |
| 17 | 2020 | 99 | |
| 18 | 2015 | 62 | |
| 19 | 2015 | 49 | |
| 20 | 1978 | 37 |
About Daniel Henderson
Daniel Henderson is a scholar working on Pulmonary and Respiratory Medicine, Genetics, Biotechnology, Endocrine and Autonomic Systems and Radiation, having authored 55 papers that have together received 5.3k indexed citations. Recurring topics across this work include Virus-based gene therapy research (11 papers), Prostate Cancer Diagnosis and Treatment (10 papers), Cancer Research and Treatments (5 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers), Advanced Radiotherapy Techniques (4 papers), Neuroscience of respiration and sleep (4 papers), CAR-T cell therapy research (3 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Genetics (1.7k citations), Critical Care and Intensive Care Medicine (203 citations), Pulmonary and Respiratory Medicine (1.2k citations), Oncology (980 citations) and Biotechnology (337 citations). Daniel Henderson has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Orly Tamir, Cyrus K. Yamin, Calvin Franz, Carol Ann Keohane, Eyal Zimlichman, David Westfall Bates, Peter X.‐K. Song, Charles R. Denham, Dechao Yu and Eric R. Schuur. Their work appears in journals such as Clinical Oncology, The Lancet Oncology, Vaccine, European Urology and Journal of Applied Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.